Fact check · Version 1 · Sources checked

“The largest randomized stroke trial proved that Cerebrolysin improves recovery.”

The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.

Misleading

This statement leaves out a limit that changes its meaning.

CASTA enrolled 1,070 adults, but its main combined recovery measure showed no significant difference between Cerebrolysin and placebo. A subgroup finding was not the main planned result and does not prove a general recovery benefit.

What this answer is based on
This answer uses a study that assigned people to groups by chance and measured a health outcome.
Limits of this answer
CASTA: adults with acute ischemic stroke studied for up to 90 days. The result applies to its planned primary measure and study population. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
Topic
What a study measured about people's health, symptoms, or ability to function.

Sources for this fact check

Show 1 sources
Sources checked by
Site editor · Editorial review

More about Cerebrolysin

See the FDA and sports-rule status of Cerebrolysin

Other fact checks on Cerebrolysin